Literature DB >> 17027649

ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains.

Kristina W Thiel1, Graham Carpenter.   

Abstract

Sequential proteolytic processing of ErbB-4 occurs in response to ligand addition. Here, we assess the localization of cleavable and non-cleavable ErbB-4 isoforms to membrane microdomains using three methodologies: (1) Triton X-100-insolubility, (2) Brij98-insolubility, and (3) detergent-free density gradient centrifugation. Whereas ErbB-4 translocated to a Triton X-100-insoluble fraction upon treatment of T47D cells with heregulin, it constitutively associated with a Brij98-insoluble fraction and a lipid raft fraction isolated using detergent-free methodology. Comparison of cleavable and non-cleavable isoforms of ErbB-4 revealed that both ErbB-4 isoforms are constitutively localized to either a Triton X-100-soluble or Brij98-insoluble fraction. In contrast, addition of heregulin resulted in translocation of the cleavable isoform to a detergent-free lipid raft. Tumor necrosis factor-alpha converting enzyme (TACE), the ectodomain secretase for ErbB-4, was present predominantly in its mature active form in most microdomains analyzed. These data suggest the assembly of ErbB-4 ectodomain cleavage apparatus in a membrane microdomain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027649      PMCID: PMC1637093          DOI: 10.1016/j.bbrc.2006.09.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Heregulin-dependent trafficking and cleavage of ErbB-4.

Authors:  W Zhou; G Carpenter
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

2.  Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4.

Authors:  Hahn-Jun Lee; Kwang-Mook Jung; Yang Z Huang; Lori B Bennett; Joanne S Lee; Lin Mei; Tae-Wan Kim
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

3.  A detergent-free method for purifying caveolae membrane from tissue culture cells.

Authors:  E J Smart; Y S Ying; C Mineo; R G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

4.  Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes.

Authors:  Y Y Zhao; O Feron; C Dessy; X Han; M A Marchionni; R A Kelly
Journal:  Circ Res       Date:  1999-06-25       Impact factor: 17.367

Review 5.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

6.  Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation.

Authors:  M Vecchi; J Baulida; G Carpenter
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

7.  gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.

Authors:  C Y Ni; M P Murphy; T E Golde; G Carpenter
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

8.  A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester.

Authors:  K Elenius; G Corfas; S Paul; C J Choi; C Rio; G D Plowman; M Klagsbrun
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

9.  Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin.

Authors:  M Vecchi; L A Rudolph-Owen; C L Brown; P J Dempsey; G Carpenter
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

10.  The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.

Authors:  Christopher C Williams; June G Allison; Gregory A Vidal; Matthew E Burow; Barbara S Beckman; Luis Marrero; Frank E Jones
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

View more
  11 in total

1.  Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.

Authors:  Juan Li; Bin Liu; Xiaofei Gao; Zhixing Ma; Tianyi CaoSong; Yan-ai Mei; Yufang Zheng
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

Review 2.  HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.

Authors:  Frank E Jones
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-13       Impact factor: 2.673

3.  Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.

Authors:  Akira Takaguri; Heigoro Shirai; Keita Kimura; Akinari Hinoki; Kunie Eguchi; MaryEllen Carlile-Klusacek; Baohua Yang; Victor Rizzo; Satoru Eguchi
Journal:  J Mol Cell Cardiol       Date:  2010-12-21       Impact factor: 5.000

4.  Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages.

Authors:  Krasimira A Rozenova; Gergana M Deevska; Alexander A Karakashian; Mariana N Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

5.  Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue.

Authors:  Kenneth H Minor; Juan C Bournat; Nicole Toscano; Roman J Giger; Stephen J A Davies
Journal:  Brain       Date:  2010-11-28       Impact factor: 13.501

6.  Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding.

Authors:  Yujian Zhang; Oleg Chertov; Jingli Zhang; Raffit Hassan; Ira Pastan
Journal:  Cancer Res       Date:  2011-07-20       Impact factor: 12.701

Review 7.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

8.  Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.

Authors:  Cristina I Caescu; Grace R Jeschke; Benjamin E Turk
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

9.  Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.

Authors:  Xinhua Chen; Johannes Fruehauf; Jeffrey D Goldsmith; Hua Xu; Kianoosh K Katchar; Hon-Wai Koon; Dezheng Zhao; Efi G Kokkotou; Charalabos Pothoulakis; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2009-05-29       Impact factor: 22.682

10.  Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells.

Authors:  Sandrine Bouchet; Ruoping Tang; Fanny Fava; Ollivier Legrand; Brigitte Bauvois
Journal:  Oncotarget       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.